Viking Therapeutics Stock Piotroski F Score

VKTX Stock  USD 51.63  0.10  0.19%   
This module uses fundamental data of Viking Therapeutics to approximate its Piotroski F score. Viking Therapeutics F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Viking Therapeutics. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Viking Therapeutics financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out Viking Therapeutics Altman Z Score, Viking Therapeutics Correlation, Viking Therapeutics Valuation, as well as analyze Viking Therapeutics Alpha and Beta and Viking Therapeutics Hype Analysis.
For more information on how to buy Viking Stock please use our How to Invest in Viking Therapeutics guide.
  
At this time, Viking Therapeutics' Short and Long Term Debt Total is fairly stable compared to the past year. Short Term Debt is likely to rise to about 919.9 K in 2024, despite the fact that Net Debt is likely to grow to (51.5 M). At this time, Viking Therapeutics' Graham Net Net is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 5.29 in 2024, whereas Free Cash Flow Yield is likely to drop (0.04) in 2024.
At this time, it appears that Viking Therapeutics' Piotroski F Score is Unavailable. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
3.0
Piotroski F Score - Unavailable
Current Return On Assets

Negative

Focus
Change in Return on Assets

Decreased

Focus
Cash Flow Return on Assets

Negative

Focus
Current Quality of Earnings (accrual)

Improving

Focus
Asset Turnover Growth

No Change

Focus
Current Ratio Change

Decrease

Focus
Long Term Debt Over Assets Change

N/A

Focus
Change In Outstending Shares

Decrease

Focus
Change in Gross Margin

No Change

Focus

Viking Therapeutics Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Viking Therapeutics is to make sure Viking is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Viking Therapeutics' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Viking Therapeutics' financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities10.4 M19.1 M
Way Down
Slightly volatile
Non Current Liabilities Total1.1 M936 K
Fairly Up
Very volatile
Total Assets386.9 M368.5 M
Sufficiently Up
Slightly volatile
Total Current Assets385.6 M367.2 M
Sufficiently Up
Slightly volatile

Viking Therapeutics F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Viking Therapeutics' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Viking Therapeutics in a much-optimized way.

About Viking Therapeutics Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Book Value Per Share

3.88

At this time, Viking Therapeutics' Book Value Per Share is fairly stable compared to the past year.

Viking Therapeutics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Viking Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Viking Therapeutics' managers, analysts, and investors.
Environmental
Governance
Social

About Viking Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Viking Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Viking Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Viking Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Viking Stock Analysis

When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.